Abstract
This research aimed to explore the molecular mechanism of microRNA (miR)-106b in cell apoptosis of atherosclerosis (AS). Human aortic endothelial cells (HAECs) were divided into control group, oxidized-low-density lipoproteins (ox-LDL) group, miR-106b NC+ox-LDL group, miR-106b mimics+ox-LDL group, miR-106b mimics+PTEN+ox-LDL group, and miR-106b mimics+empty+ox-LDL group. Real-time fluorescence quantitative polymerase chain reaction, cholecystokinin, TdT-mediated biotinylated nick end-labeling assay, luciferase reporter gene assay, and flow cytometry analysis were performed to determine the morphology, proliferation, and apoptosis in HSECs. Moreover, the levels of phosphatase and tensin homolog deleted on chromosome 10 (PTEN), Bcl-2, p-P13K, and p-AKT in HAECs were detected by western blot. MiR-106b was down-regulated in ox-LDL-induced HAECs. PTEN was the target gene of miR-106b-5p. Overexpression of PTEN inhibited the anti-apoptotic effect of miR-106b. Compared with the control group, the proportion and number of HAECs apoptosis and Bax, caspase-3, and caspase-9 expression in ox-LDL and miR-106b mimics+PTEN+ox-LDL groups were significantly increased (all P<0.05). Moreover, the activity of HAECs and Bcl-2 were decreased signific...Continue Reading
References
Aug 27, 1993·Cell·Z N OltvaiS J Korsmeyer
Sep 11, 2001·Journal of Molecular and Cellular Cardiology·J C ChoyB M McManus
Jan 11, 2002·The Journal of Biological Chemistry·Jianhua Huang, Christopher D Kontos
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jan 24, 2008·Molecular and Cellular Biology·Irena IvanovskaMichele A Cleary
Sep 30, 2010·The Prostate·Baoqing LiRalph de Vere White
May 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Masahiro KoideHiroaki Matsubara
Aug 31, 2010·Atherosclerosis·Hsiao-Mei KuoMing-Hong Tai
May 23, 2012·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Zhihua LiuXiaobo Sun
Dec 18, 2013·PloS One·Jingyi RenHong Chen
Sep 6, 2014·Natural Product Research·Amirhossein Sahebkar
Apr 8, 2015·Vascular Pharmacology·Meng QinXiao-bo Sun
Apr 15, 2015·The Journal of Cell Biology·Ira TabasGary K Owens
May 2, 2015·PloS One·Shuo ChenYang Zhao
Aug 5, 2015·Journal of Translational Medicine·Lin ZhengXuenong Li
Sep 29, 2015·The FEBS Journal·Janet H ZhengTudor Moldoveanu
Dec 10, 2015·Molecular Medicine Reports·Yifan LiYongqing Lai
Dec 19, 2015·Immunology Letters·Hao YanLing Tao
Feb 20, 2016·Circulation Research·Mark W Feinberg, Kathryn J Moore
Mar 30, 2016·Molecular Neurobiology·Pengfei LiChunbing Zhang
Jun 9, 2016·Chinese Medical Journal·Jing ZhangJun-Xian Song
Jul 29, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Kai ZhouDangmurenjiafu Geng
Sep 19, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Zheng LuXianen Fa
Oct 21, 2016·The Journal of Pharmacy and Pharmacology·Ewa SkałaTomasz Śliwiński
Dec 23, 2016·AJNR. American Journal of Neuroradiology·J YuanM J Graves
Feb 18, 2017·Nature Reviews. Drug Discovery·Avi AshkenaziAndrew J Souers
Mar 14, 2017·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Zhiming ZhengTao Song
May 26, 2017·Cellular & Molecular Biology Letters·Ying LiPing Yang
Aug 22, 2017·Experimental Cell Research·Feng TangLi Gong
Feb 9, 2018·OncoTargets and Therapy·Dong-Min ShiWei-Zhong Wu
Feb 10, 2018·Autoimmunity Reviews·Claudia Floriana SuciuFederico Perosa
Mar 15, 2018·Journal of Cardiovascular Medicine·Antonio MicariAlberto Cremonesi
Apr 13, 2018·Oncotarget·Bingye XueJenny T Mao
Jun 28, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Bing QinZhengqi Lu